Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Commentary

Clinical trial update: International Breast Cancer Study Group

Karen N Price1 email and Aron Goldhirsch2,3 for the International Breast Cancer Study Group

1International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, Massachusetts, USA

2Oncology Institute of Southern Switzerland, Bellinzona, Mendrisio, Lugano, Switzerland

3European Institute of Oncology, Milan, Italy

author email corresponding author email

Breast Cancer Research 2005, 7:252-254doi:10.1186/bcr1334

Published: 4 October 2005

Abstract

The International Breast Cancer Study Group (IBCSG) has been conducting large, phase III clinical trials since 1978. Prior to 1986, these activities were carried out under the name of Ludwig Breast Cancer Study Group. Seven trials of adjuvant therapies are currently open for patient accrual, five of which are described in this report. The IBCSG has been a leader in the field of tailored treatment approaches for specific subpopulations of patients with breast cancer, believing that what is best for the majority may not be best for a defined minority.


© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.